Privat Doktor Egeszseguegyi Szolgaltato Zrt.

The cardiology department at Privat Doktor Egeszsegugyi Szolgaltato Zrt. conducts a broad portfolio of studies aimed at major cardiovascular diseases including atherosclerotic disease, atrial fibrillation, heart failure, and hypertension, with the goal of testing new therapies and improving patient outcomes.

• Reducing major adverse cardiovascular events in high‑risk populations
• Preventing stroke in patients with atrial fibrillation unsuitable for anticoagulation
• Slowing chronic kidney disease progression in individuals with hypertension
• Improving survival and hospitalization rates in heart failure with preserved or reduced ejection fraction
• Targeting elevated lipoprotein(a) and LDL‑C levels
• Assessing anti‑inflammatory interventions after myocardial infarction

Based in Budapest, the centre has launched 19 trials with five investigators, partnering with academic and industry collaborators to evaluate innovative drugs and combination regimens for cardiovascular risk reduction.

Research at the site also focuses on nutritional and metabolic disorders, addressing obesity, type 2 diabetes, hyperlipidemia, and severe hypertriglyceridemia, with studies designed to test novel agents that modify metabolic pathways and improve clinical outcomes.

• Evaluating therapies that lower fasting triglyceride concentrations
• Testing weight‑loss agents that also improve glycemic control
• Investigating treatments that reduce lipoprotein(a) and LDL‑C in inherited hypercholesterolemia
• Exploring combination regimens for hypertension in patients with metabolic syndrome
• Assessing drugs that prevent acute pancreatitis in severe hypertriglyceridemia

The Budapest facility leverages its multidisciplinary expertise to advance therapeutic options for metabolic disease, contributing to the growing evidence base that links metabolic health with cardiovascular risk.